Getinge AB ser. B

ST:GETI-B Sweden Medical Devices
Market Cap
$4.30 Billion
Skr48.19 Billion SEK
Market Cap Rank
#3931 Global
#18 in Sweden
Share Price
Skr189.60
Change (1 day)
+0.72%
52-Week Range
Skr178.80 - Skr227.80
All Time High
Skr408.59
Categories
Companies in Sweden Medical Devices
About

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage so… Read more

Getinge AB ser. B (GETI-B) - Net Assets

Latest net assets as of December 2025: Skr29.49 Billion SEK

Based on the latest financial reports, Getinge AB ser. B (GETI-B) has net assets worth Skr29.49 Billion SEK as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr56.51 Billion) and total liabilities (Skr27.01 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr29.49 Billion
% of Total Assets 52.2%
Annual Growth Rate 10.2%
5-Year Change 17.15%
10-Year Change 41.01%
Growth Volatility 13.66

Getinge AB ser. B - Net Assets Trend (2002–2025)

This chart illustrates how Getinge AB ser. B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Getinge AB ser. B (2002–2025)

The table below shows the annual net assets of Getinge AB ser. B from 2002 to 2025.

Year Net Assets Change
2025-12-31 Skr29.49 Billion -11.19%
2024-12-31 Skr33.21 Billion +9.23%
2023-12-31 Skr30.40 Billion -0.16%
2022-12-31 Skr30.45 Billion +20.96%
2021-12-31 Skr25.18 Billion +17.17%
2020-12-31 Skr21.49 Billion +2.45%
2019-12-31 Skr20.97 Billion +6.71%
2018-12-31 Skr19.66 Billion -0.76%
2017-12-31 Skr19.81 Billion -5.31%
2016-12-31 Skr20.92 Billion +6.75%
2015-12-31 Skr19.59 Billion +4.81%
2014-12-31 Skr18.69 Billion +12.89%
2013-12-31 Skr16.56 Billion +8.95%
2012-12-31 Skr15.20 Billion +3.85%
2011-12-31 Skr14.64 Billion +10.48%
2010-12-31 Skr13.25 Billion +5.46%
2009-12-31 Skr12.56 Billion +17.67%
2008-12-31 Skr10.68 Billion +61.20%
2007-12-31 Skr6.62 Billion +10.29%
2006-12-31 Skr6.00 Billion +11.59%
2005-12-31 Skr5.38 Billion +26.04%
2004-12-31 Skr4.27 Billion +20.94%
2003-12-31 Skr3.53 Billion +11.79%
2002-12-31 Skr3.16 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Getinge AB ser. B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1819.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings Skr21.50 Billion 73.07%
Common Stock Skr136.00 Million 0.46%
Other Comprehensive Income Skr1.00 Billion 3.40%
Other Components Skr6.79 Billion 23.07%
Total Equity Skr29.43 Billion 100.00%

Getinge AB ser. B Competitors by Market Cap

The table below lists competitors of Getinge AB ser. B ranked by their market capitalization.

Company Market Cap
Azrieli Group Ltd
OTCGREY:AZRGF
 		$3.03 Billion
Standex International Corporation
NYSE:SXI
 		$3.03 Billion
Boyd Group Services Inc
PINK:BYDGF
 		$3.03 Billion
Sichuan Yahua Industrial Group Co Ltd
SHE:002497
 		$3.03 Billion
Hayward Holdings Inc
NYSE:HAYW
 		$3.03 Billion
Sinolink Securities Co Ltd
SHG:600109
 		$3.03 Billion
Tube Investments of India Limited
NSE:TIINDIA
 		$3.03 Billion
HASEKO Corporation
F:HS6
 		$3.03 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Getinge AB ser. B's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 33,005,000,000 to 29,429,000,000, a change of -3,576,000,000 (-10.8%).
  • Net income of 2,258,000,000 contributed positively to equity growth.
  • Dividend payments of 1,253,000,000 reduced retained earnings.
  • Other comprehensive income decreased equity by 4,752,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr2.26 Billion +7.67%
Dividends Paid Skr1.25 Billion -4.26%
Other Comprehensive Income Skr-4.75 Billion -16.15%
Other Changes Skr171.00 Million +0.58%
Total Change Skr- -10.83%

Book Value vs Market Value Analysis

This analysis compares Getinge AB ser. B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.75x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 13.30x to 1.75x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 Skr14.26 Skr189.60 x
2003-12-31 Skr15.94 Skr189.60 x
2004-12-31 Skr19.06 Skr189.60 x
2005-12-31 Skr23.96 Skr189.60 x
2006-12-31 Skr27.01 Skr189.60 x
2007-12-31 Skr29.50 Skr189.60 x
2008-12-31 Skr47.63 Skr189.60 x
2009-12-31 Skr49.60 Skr189.60 x
2010-12-31 Skr52.31 Skr189.60 x
2011-12-31 Skr57.79 Skr189.60 x
2012-12-31 Skr60.01 Skr189.60 x
2013-12-31 Skr65.40 Skr189.60 x
2014-12-31 Skr72.56 Skr189.60 x
2015-12-31 Skr75.97 Skr189.60 x
2016-12-31 Skr84.82 Skr189.60 x
2017-12-31 Skr77.31 Skr189.60 x
2018-12-31 Skr70.50 Skr189.60 x
2019-12-31 Skr75.25 Skr189.60 x
2020-12-31 Skr77.19 Skr189.60 x
2021-12-31 Skr90.87 Skr189.60 x
2022-12-31 Skr110.28 Skr189.60 x
2023-12-31 Skr110.75 Skr189.60 x
2024-12-31 Skr121.18 Skr189.60 x
2025-12-31 Skr108.05 Skr189.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Getinge AB ser. B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.67%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.46%
  • • Asset Turnover: 0.62x
  • • Equity Multiplier: 1.92x
  • Recent ROE (7.67%) is below the historical average (12.92%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 19.69% 7.20% 0.91x 3.00x Skr305.88 Million
2003 22.03% 8.49% 0.76x 3.41x Skr424.66 Million
2004 27.20% 10.54% 0.87x 2.95x Skr725.74 Million
2005 21.45% 9.58% 0.82x 2.74x Skr607.66 Million
2006 20.96% 9.65% 0.82x 2.65x Skr655.70 Million
2007 19.10% 7.66% 0.72x 3.48x Skr600.20 Million
2008 14.30% 7.90% 0.58x 3.10x Skr457.80 Million
2009 15.27% 8.39% 0.61x 2.99x Skr660.20 Million
2010 17.22% 10.27% 0.64x 2.62x Skr954.70 Million
2011 17.31% 11.57% 0.53x 2.84x Skr1.07 Billion
2012 16.62% 10.40% 0.56x 2.83x Skr1.00 Billion
2013 13.82% 9.04% 0.57x 2.68x Skr631.90 Million
2014 7.81% 5.37% 0.50x 2.88x Skr-401.20 Million
2015 7.24% 4.60% 0.57x 2.77x Skr-530.30 Million
2016 5.79% 3.99% 0.54x 2.69x Skr-862.80 Million
2017 7.10% 6.12% 0.53x 2.17x Skr-562.40 Million
2018 -5.04% -4.00% 0.56x 2.26x Skr-2.89 Billion
2019 5.96% 4.60% 0.59x 2.18x Skr-827.60 Million
2020 15.41% 10.86% 0.66x 2.14x Skr1.14 Billion
2021 12.00% 10.98% 0.61x 1.80x Skr495.10 Million
2022 8.29% 8.80% 0.54x 1.73x Skr-512.80 Million
2023 8.00% 7.58% 0.59x 1.78x Skr-604.60 Million
2024 4.96% 4.71% 0.54x 1.94x Skr-1.66 Billion
2025 7.67% 6.46% 0.62x 1.92x Skr-684.90 Million

Industry Comparison

This section compares Getinge AB ser. B's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $75,200,026
  • Average return on equity (ROE) among peers: -74.39%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Getinge AB ser. B (GETI-B) Skr29.49 Billion 19.69% 0.92x $3.03 Billion
Acarix A/S (ACARIX) $76.60 Million -60.65% 0.08x $28.86 Million
Arcoma AB (ARCOMA) $12.52 Million -92.85% 4.66x $8.93 Million
Bactiguard Holding AB (publ) (BACTI-B) $353.18 Million -39.18% 0.87x $19.20 Million
CellaVision AB (CEVI) $20.07 Million 13.08% 1.20x $262.59 Million
Clinical Laserthermia Systems AB (publ) (CLS-B) $65.69 Million -72.50% 0.20x $13.78 Million
Chordate Medical Holding AB (CMH) $38.95 Million -55.88% 0.13x $17.64K
Coala Life Group AB (COALA) $52.33 Million -287.99% 0.53x $468.93K
C-Rad AB (publ) (CRAD-B) $93.64 Million 22.63% 0.57x $56.67 Million
Duearity AB (DEAR) $-2.39 Million 0.00% 0.00x $34.43K
Episurf Medical AB (publ) (EPIS-B) $41.40 Million -170.53% 0.39x $5.40 Million